GraniteShares Platinum Trust: Form 10-Q for the period ended Mar 31, 2025
Filed with the SEC on May 8, 2025 and accepted by EDGAR at May 8, 2025, 20:34 ET.
Management's discussion and analysis
As filed, 8,355 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
This information should be read in conjunction with the financial statements and notes to the financial statements included in Item 1 of Part I of this Form 10-Q. The discussion and analysis that follows may contain statements that relate to future events or future performance. In some cases, such forward-looking statements can be identified by terminology such as “may,” “should,” “could,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential” or the negative of these terms or other comparable terminology. Except as required by applicable disclosure laws, neither the Sponsor, nor any other person assumes responsibility for the accuracy or completeness of any forward-looking statements. Neither the Trust nor the Sponsor is under a duty to update any of the forward-looking statements to conform such statements to actual results or to a change in the Sponsor’s expectations or predictions.
Introduction
The Trust is a common law trust, formed under the laws of the state of New York on January 11, 2018. The Trust is not managed like a corporation or an active investment vehicle. It does not have any officers, directors, or employees and is administered by the Trustee pursuant to the Trust Agreement. The Trust is not registered as an investment company under the Investment Company Act of 1940 and is not required to register under such act. It does not hold or trade in commodity futures contracts, nor is it a commodity pool, or subject to regulation as a commodity pool operator or a commodity trading adviser in connection with issuing Shares.
The Trust holds platinum and is expected to issue Baskets in exchange for deposits of platinum, and to distribute platinum in connection with redemptions of Baskets. Shares issued by the Trust represent units of undivided beneficial interest in and ownership of the Trust. The investment objective of the Trust is for the Shares to reflect the performance of the price of platinum, less the Trust’s expenses. The Sponsor believes that, for many investors, the Shares will represent a cost-effective investment relative to traditional means of investing in platinum.
The Trust issues and redeems Shares only with Authorized Participants in exchange for platinum and only in aggregations of 50,000 Shares or integral multiples thereof. A list of current Authorized Participants is available from the Sponsor or the Trustee.
Shares of the Trust trade on the New York Stock Exchange (the “NYSE”) Arca under the symbol “PLTM”.
Valuation of Platinum; Computation of Net Asset Value
On each business day, as soon as practicable after 4:00 p.m. (New York time), the Trustee evaluates the platinum held by the Trust and determines the net asset value of the Trust and the NAV. The Trustee values the platinum held by the Trust using that day’s LBMA Platinum Price PM. If there is no announced LBMA Platinum PM on a business day, the Trustee is authorized to use that day’s LBMA Platinum Price AM. Having valued the platinum held by the Trust, the Trustee then subtracts all accrued fees, expenses and other liabilities of the Trust from the value of the platinum and other assets of the Trust. The result is the net asset value of the Trust. The Trustee computes the NAV by dividing the net asset value of the Trust by the number of Shares outstanding on the date the computation is made.
Liquidity and Capital Resources
The Trust is not aware of any trends, demands, commitments, events or uncertainties that are reasonably likely to result in material changes to its liquidity needs. In exchange for the Sponsor’s Fee, the Sponsor has agreed to assume most of the expenses incurred by the Trust. As a result, the only ordinary expense of the Trust during the period covered by this report was the Sponsor’s Fee.
The Trustee will, at the direction of the Sponsor or in its own discretion, sell the Trust’s platinum as necessary to pay the Trust’s expenses not otherwise assumed by the Sponsor. The Trustee will not sell platinum to pay the Sponsor’s Fee but will pay the Sponsor’s Fee through in-kind transfers of platinum to the Sponsor. At March 31, 2025 the Trust did not have any cash balances.
Off-Balance Sheet Arrangements
The Trust has no off-balance sheet arrangements.
Critical Accounting Policies
The financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements relies on estimates and assumptions that impact the Trust’s financial position and results of operations. These estimates and assumptions affect the Trust’s application of accounting policies. Below, the Trust describes the valuation of platinum bullion, a critical accounting policy that the Trust believes is important to understanding its results of operations and financial position. In addition, please refer to Note 2 to the financial statements included in this report for further discussion of the Trust’s accounting policies.
Results of Operations
The Quarter Ended March 31, 2025
The Trust’s net asset value increased from $45,904,688 on December 31, 2024 to $50,291,907 on March 31, 2025, a 9.56% increase. The Trust’s net asset value increase was due to the positive change in the price of platinum, which moved from $914.00 on December 31, 2024 to $993.00 on March 31, 2025, or 8.64%. The impact of the change in platinum price was slightly increased by a positive change in the number of shares outstanding from 5,200,000 to 5,250,000, or 0.96%. The 50,000 shares increase was the result of 4 creation orders and 3 redemption orders (50,000 shares per creation order).
The 8.49% increase in the Trust’s net asset value per share, from $8.83 on December 31, 2024, to $9.58 on March 31, 2025, is directly related to the 8.64% increase in the price of platinum.
The Trust’s net asset value per share increased slightly less than the price of platinum on a percentage basis due to the Sponsor’s fees, which were $61,502 for the quarter, or 0.123% of the Trust’s average weighted net assets of $49,885,104 during the quarter. The net asset value per share of $9.66 on March 19, 2025, was the highest during the quarter, compared with a low during the quarter of $8.83 on January 02, 2025.
The net increase in net assets resulting from operations for the quarter ended March 31, 2025, was $4,008,040, resulting from an unrealized gain on investment in platinum bullion of $4,096,030, decreased by a loss of $26,488 on metal sold to cover the redemption orders and the Sponsor’s fees and decreased by the Sponsor’s fees of $61,502. Other than the Sponsor’s fees the Trust had no expenses during the quarter.
Nine Months Ended March 31, 2025
The Trust’s net asset value increased from $43,119,274 on June 30, 2024 to $50,291,907 on March 31, 2025, a 16.63% increase. The Trust’s number of shares outstanding increased from 4,400,000 to 5,250,000 over this period, or 19.32%. The 850,000 shares increase was the net result of 24 creations orders and 7 redemption orders (50,000 shares per creation and redemption order). The positive impact in the number of shares outstanding was reduced by the price of platinum, which decreased 1.88% from $1,012.00 on June 30, 2024, to $993.00 on March 31, 2025.
The 2.24% decrease in the Trust’s net asset value per share, from $9.80 on June 30, 2024, to $9.58 on March 31, 2025, is directly related to the 1.88% decrease in the price of platinum.
The Trust’s net asset value per share decreased slightly more than the price of platinum on a percentage basis due to the Sponsor’s fees, which were $168,946 for the period, or 0.375% of the Trust’s average weighted net assets of $45,011,536 during the period. The net asset value per share of $10.15 on October 30,2024 was the highest during the period, compared with a low during the period of $8.80 on September 05, 2024.
Net decrease in net assets resulting from operations for the 9 months period ending March 31, 2025, was $582,955, resulting from an unrealized loss on investment in platinum bullion of $226,183, decreased by a loss of $187,826 on metal sold to cover the redemption orders and the Sponsor’s fees, and by the Sponsor’s fees of $168,946. Other than the Sponsor’s fees the Trust had no expenses during the quarter.
Controls and procedures
As filed, 1,432 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Disclosure Controls and Procedures
The duly authorized officers of the Sponsor, performing functions equivalent to those a principal executive officer and principal financial officer of the Trust would perform if the Trust had any officers, have evaluated the effectiveness of the Trust’s disclosure controls and procedures, and have concluded that the disclosure controls and procedures of the Trust were effective as of the end of the period covered by this report. Such disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed in the reports that the Trust files or submits under the Securities Exchange Act of 1934, as amended, are recorded, processed, summarized and reported, within the time period specified in the applicable rules and forms, and that such information is accumulated and communicated to the duly authorized officers of the Sponsor performing functions equivalent to those a principal executive officer and principal financial officer of the Trust would perform if the Trust had any officers to allow timely decisions regarding required disclosure.
Internal Control over Financial Reporting
There has been no change in the internal control over financial reporting that occurred during the fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Trust’s internal control over financial reporting.
Risk factors
As filed, 636 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
You should carefully consider the factors discussed from page 8 “Risk Factors” in our prospectus dated January 23, 2024, filed pursuant to Rule 424(b)(3) under the Securities Act of 1933, as amended, with the U.S. Securities and Exchange Commission, file number 333-276531, which could materially affect our business, financial condition or future results. The risks described in the prospectus are not the only risks facing the Trust. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Net income | 3 months2025-01-01 to 2025-03-31 | $4.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-07-01 to 2025-03-31 | −$583.0k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-01-01 to 2025-03-31 | $0.75 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-07-01 to 2025-03-31 | −$0.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-01-01 to 2025-03-31 | $0.75 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-07-01 to 2025-03-31 | −$0.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-01-01 to 2025-03-31 | 5,342,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-07-01 to 2025-03-31 | 4,823,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Total assets | At period end2025-03-31 | $50.3m | us-gaap:Assets |
| Total liabilities | At period end2025-03-31 | $21.0k | us-gaap:Liabilities |
Source: SEC EDGAR, the filing index for accession 0001641172-25-009284. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.